Tainá Silveira Alano

Tainá Silveira Alano

Auto-generated profile, based on publicly available information

Tainá Silveira Alano

Hospital de Clínicas de Porto Alegre

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2022 in American Journal of Hospice and Palliative Medicine®
Verified
Journal Article
Closed access
SSSoraya C. Ito Suffert
Soraya C. Ito Suffert
BMBruna B. Motke
Bruna B. Motke
ALArmani B. Linhares
Armani B. Linhares
AVAndré F. Vargens
André F. Vargens
TATainá S. Alano
Tainá S. Alano
RARafael José Vargas Alves
Rafael José Vargas Alves
Background: An estimated 9.6 million people died from cancer globally in 2018, which is a reflection of the quality of patients’ end-of-life care and its costs. Aim: To estimate direct medical costs of the last 30 days of oncology patients admitted to an inpatient clinic and to evaluate factors associated with medical costs at the end of life. Design: Cost-of-illness study with data from a retrospective cohort. Setting/Participants: We included patients aged 18 and older who were diagnosed with incurable cancer and who were admitted to a tertiary hospital in Brazil between January 1, 2018 and December 31, 2019. Results: Our sample included 109 patients with an average age of 69 (61‒76). The median overall survival was 4.3 (.9‒12.9) months. The median cost per patient per day related to hospitalization was BRL 119 (73‒181)/United States dollars [USD] 21 (13‒33). The cost of medication was BRL 66 (40‒105)/USD 12 (7‒19), representing 55.46% of costs while that of materials and supplies was BRL 30 (18‒49)/USD 5 (3‒9). In the multivariate analysis, when the limitation of interventions was recorded in the medical record, the median cost is reduced by BRL 50 (USD 9) per patient per day. Conclusions: The median cost per patient per day was BRL 119 (73‒181). The recording of limitations of therapeutic interventions in the medical record was a predictor variable that influenced the final medical cost of patients, suggesting that medical practice and decision-making in end-of-life care impact costs.

5 October 2023 in Research Square
Verified
Preprint
Open access
PDF file
AIAndresa Conrado Ignacio
Andresa Conrado Ignacio
NONórton Luís Oliveira
Nórton Luís Oliveira
LSLarissa Xavier Neves da Silva
Larissa Xavier Neves da Silva
JLJayne Santos Leite
Jayne Santos Leite
ANAngélica Trevisan De Nardi
Angélica Trevisan De Nardi
DUDaniel Umpierre
Daniel Umpierre
Background In response to the growing number of published randomized clinical trials (RCTs), efforts have been made to promote transparent and reproducible research practices. However, limited evidence exists to demonstrate the level of adherence to established reporting and methodological standards. This study aimed to evaluate the methodological standards and quality of reporting in RCTs of physical activity (PA) interventions. We aimed to present Strengthening the Evidence in Exercise Sciences Initiative (SEES Initiative) 2020 assessments results. Methods RCTs of PA advice or exercise interventions published in 2020 were selected. Monthly searches were conducted on PubMed/MEDLINE targeting six top-tier exercise science journals. Assessments were conducted by two independent authors, based on 44 items originally from CONSORT and TIDieR reporting guidelines. These items were divided into seven domains: transparency, completeness, participants, intervention, rigor methodology, outcomes and critical analysis. Descriptive analysis was performed using absolute and relative frequencies, and exploratory analysis was done by comparing proportions using the X2^test (α = 0.05). Results Out of 1,766 RCTs evaluated for eligibility, 53 were included. The median adherence to recommended items included among the studies was 30, ranging from 18 (41%) to 44 (100%) items in individual study assessments. The items presenting full adherence among the studies were related to intervention description, justification, outcome measurement, effect sizes, and statistical analysis. The least reported item referred to mentioning unplanned modifications during trials, appearing in 6 (11.3%) studies. Out of the 53 RCTs, 36 (67.9%) reported having a registration, and these studies demonstrated higher adherence to the assessed items compared to non-registered studies. Conclusions In general, items related to critical analysis were more thoroughly described, such as hypotheses and statistical analyses. However, aspects more related to transparency aspects, such as protocol registrations/modifications and intervention descriptions, were suboptimally reported. Finally, this study highlights the need to promote the existing resources concerning quality of reporting and transparent research practices for investigators and editors in the exercise sciences discipline.